(Q37944195)

25 August 2017

Vitamin D and multiple sclerosis: review of a possible association (English)

1 reference

25 August 2017

0 references

0 references

0 references

Nicole Marie Summerday

1

1 reference

25 August 2017

Sherrill J Brown

2

1 reference

25 August 2017

Douglas R Allington

3

1 reference

25 August 2017

Michael P Rivey

4

1 reference

25 August 2017

1 February 2012

1 reference

Journal of Pharmacy Practice

25 August 2017

1 reference

25 August 2017

25

1 reference

25 August 2017

1

1 reference

25 August 2017

75-84

1 reference

Clinical implications of a possible role of vitamin D in multiple sclerosis

25 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

The prevalence of multiple sclerosis in the world: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

Vitamin D: A millenium perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

Vitamin D and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

Immunotherapeutic approaches in MS: update on pathophysiology and emerging agents or strategies 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

Identification and development of new therapeutics for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

Vitamin D and autoimmunity: new aetiological and therapeutic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

Multiple sclerosis--the plaque and its pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

Vitamin D deficiency in adults: when to test and how to treat

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

What is next for the Dietary Reference Intakes for bone metabolism related nutrients beyond calcium: phosphorus, magnesium, vitamin D, and fluoride?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

Vitamin D intake and incidence of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

Immunomodulatory effects of Vitamin D in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

The epidemiology of multiple sclerosis in Queensland, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190011421839

21 January 2018

Identifiers

DOI

10.1177/0897190011421839

1 reference

25 August 2017

1 reference